Prevalence of Hepatitis B Virus, Human Immune Deficiency Virus and Associated Risk Factors Among Individuals with Presumptive Pulmonary Tuberculosis Attending at Saint Peter’s Specialized Hospital, Addis Ababa, Ethiopia

References

• World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva; 2015. Availablefrom: http://apps.who.int/iris/bitstream/10665/154590/1/9789241549059_eng.pdf. Accessed June 14, 2023.
   Google Scholar
• The Center for Public Policy Research and Ethics The AIDS Institute. The co-infection of HIV/AIDS and hepatitis B and C: the socio-economic impact on the state of Florida; 2017. Available from: http://www.theaidsinstitute.org. Accessed June 14, 2023.
   Google Scholar
• Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45(2):507–539. doi:10.1002/hep.21513
   PubMed Web of Science ®Google Scholar
• Al-Jabir AA, Al-Adawi S, Al-Abri JH, Al-Dhahry SH. Awareness of hepatitis B virus among undergraduate medical and non-medical students. Saudi Med J. 2004;25:484–487.
   PubMed Web of Science ®Google Scholar
• Lesi O Hepatitis B in Africa: the challenges in controlling the scourge; 2015. Available from: https://theconversation.com. Accessed June 14, 2023.
   Google Scholar
• Bwogi J, Braka F, Makumbi I, et al. Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey. Afr Health Sci. 2009;9:98–108. doi:10.1371/journal.pone.0003919
   PubMed Web of Science ®Google Scholar
• WHO fact sheet; HIV and AIDS. 2017. Available from: http://www.who.int/mediacentre/factsheets/fs360/en/. Accessed June 14, 2023.
   Google Scholar
• Alexander K, Mirja K, And Klaus K. Modern infectious disease epidemiology concepts, methods, mathematical models, and public health; 2010. Available from: http://www.springer.com/series/2848. Accessed June 14, 2023.
   Google Scholar
• USAIDS. Global HIV & AIDs statistics updated on; 2017. Available from: https://www.avert.org/global-hiv-and-aids-statistics. Accessed June 14, 2023.
   Google Scholar
• World Health Organization. Global Tuberculosis report; 2017. Available from: http://www.who.int/tb/publications/global_report/en/. Accessed June 14, 2023.
   Google Scholar
• World Health Organization. Global Tuberculosis report; 2016. Available from: http://apps.who.int/iris/bitstream/10665/250441/1/9789241565394-eng.pdf. Accessed June 14, 2023.
   Google Scholar
• World Health Organization. Tuberculosis Fact sheet; 2017. Available from: http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed June 14, 2023.
   Google Scholar
• Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis. 2007;6:402–409. doi:10.1016/S1473-3099(07)70135-4
   Google Scholar
• Smith I. Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence. Clin Microbiol Rev. 2003;16(3):463–496. doi:10.1128/CMR.16.3.463-496.2003
   PubMed Web of Science ®Google Scholar
• World Health Organization. TB/HIV: a clinical manual. China: World Health Organization; 2004. Available from: http://whqlibdoc.who.int/publications/2004/9241546344.pdf. Accessed June 14, 2023.
   Google Scholar
• Podlekareva DN, Panteleev AM, Grint D, et al. Short and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. Eur Respir J. 2014;43:166–177.
   PubMed Web of Science ®Google Scholar
• Ungo JR, Jones D, Ashkin D, et al. Anti tuberculosis drug-induced hepatotoxicity. The role of hepatitis C virus and the HIV. Am J RespirCrit Care Med. 1998;157:1871–1876. doi:10.1164/ajrccm.157.6.9711039
   PubMed Web of Science ®Google Scholar
• Chien JY, Huang RM, Wang JY, et al. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2010;14:616–621.
   PubMed Web of Science ®Google Scholar
• Pingzheng MO, Zhu QI, Teter C, et al. Prevalence, drug-induced hepatotoxicity, and mortality among patients multi-infected with HIV, tuberculosis, and hepatitis virus. Inter J Infect Dis. 2014;28:95–100. doi:10.1016/j.ijid.2014.06.020
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO advises on the use of multi disease testing devices for TB, HIV and hepatitis. Geneva: World Health Organization; 2017. Available from: http://www.who.int/hiv/mediacentre/news/multidisease-testing-hiv-tb-hepatitis/en/. Accessed June 14, 2023.
   Google Scholar
• Wang JY, Liu CH, Hu FC, et al. Risk factors during anti tuberculosis treatment and implications of hepatitis virus load. J Infect. 2011;62:448–455. doi:10.1016/j.jinf.2011.04.005
   PubMed Web of Science ®Google Scholar
• Mengesha E, Airgecho T, Negera E, Mulugeta K. Kebede M.Prevalence of triple viral infections of human immunodeficiency virus (HIV), hepatitis B and C among tuberculosis patients and associated risk factors: the case of West Arsi Zone, Ethiopia. Afr J Microb Res. 2015;9(26):1675–1683. doi:10.5897/AJMR2015.7583
   Google Scholar
• Abera B, Adem Y, Yimer M, Mulu W, Zenebe Y, Mekonnen Z. Community Seroprevalence of hepatitis B, C and human immunodeficiency virus in adult population in Gojjam zones, northwest Ethiopia. Virol J. 2017;14:21. doi:10.1186/s12985-017-0696-6
   PubMed Web of Science ®Google Scholar
• Amiri FB, Gouya MM, Saifi M, et al. Vulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitis. PLoS One. 2014;9(6):e98742. doi:10.1371/journal.pone.0098742
   PubMed Web of Science ®Google Scholar
• Yami A, Alemseged F, Hassen A. Hepatitis B and C viruses infections and their association with human immunodeficiency virus: a cross-sectional study among blood Donors in Ethiopia. Ethiop J Health Sci. 2011;21(1):67–75. doi:10.4314/ejhs.v21i1.69047
   PubMedGoogle Scholar
• Erena AN, Tefera TB. Prevalence of hepatitis B surface antigen (HBsAg) and its risk factors among individuals visiting Goba General Hospital, South East Ethiopia, 2012. BMC Res Notes. 2014;7(1):833. doi:10.1186/1756-0500-7-833
   PubMedGoogle Scholar
• Gebremariam AA, Tsegaye AT, Shiferaw YF, Reta MM, Getaneh A. Seroprevalence of Hepatitis B virus and associated factors among health professionals in University of Gondar Hospital, Northwest Ethiopia. Adv Prev Med. 2019;2019:5. doi:10.1155/2019/7136763
   Google Scholar
• Zenebe Y, Mulu W, Yimer M, Abera B. Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2014;14:118. doi:10.1186/1471-2334-14-118
   PubMed Web of Science ®Google Scholar
• ICF International. HIV/AIDS in Ethiopia: data from the 2011 Ethiopia Demographic and Health Survey. Calverton, Maryland, USA: ICF International; 2017. Available from: https://dhsprogram.com/pubs/pdf/DM26/DM26.pdf. Accessed June 14, 2023.
   Google Scholar
• Endris M, Deressa T, Belyhun Y, Moges F. Seroprevalence of syphilis and human immunodeficiency virus infections among pregnant women who attend the University of Gondar teaching hospital, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2015;15(1):111. doi:10.1186/s12879-015-0848-5
   PubMedGoogle Scholar
• Alemayehu M, Wubshet M, Mesfin N, Gebayehu A. Prevalence of human immunodeficiency virus and associated factors among Visceral Leishmaniasis infected patients in Northwest Ethiopia: a facility based cross-sectional study. BMC Infect Dis. 2017;152. doi:10.1186/s12879-017-2261-8
   PubMedGoogle Scholar
• Hussain T, Kulshreshtha KK, Yadav VS, Katoch K. HIV and HBV co-infections among patients with active TB disease attending a primary health care centre in a rural area of north India. Egypt J Chest Dis Tubercul. 2016;65:227–232. doi:10.1016/j.ejcdt.2015.08.009
   Google Scholar
• Weldemhret L, Asmelash T, Belodu R, Gebreegziabiher D. Sero-prevalence of HBV and associated risk factors among HIV positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia. AIDS Res Ther. 2016;13(6). doi:10.1186/s12981-016-0090-2
   PubMedGoogle Scholar
• Abera A, Ameya G. Pulmonary tuberculosis and associated factors among diabetic patients attending hawassa adare hospital, Southern Ethiopia. Open Microbiol J. 2018;12:333–342. doi:10.2174/1874285801812010333
   PubMedGoogle Scholar
• Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19(1):307. doi:10.1186/s12879-019-3943-1
   PubMedGoogle Scholar
• Farhoudi B, SeyedAlinaghi SA, Mohraz M, Hosseini M, Farnia M. Farnia.M.tuberculosis, hepatitis C and hepatitis B co-infections in patients with HIV in the Great Tehran Prison. Iran Asian Pac J Trop Dis. 2016;6(1):82–83. doi:10.1016/S2222-1808(15)60989-6
   Google Scholar
• da Motta LR, Adami ADG, Sperhacke RD, et al. Hepatitis B and C prevalence and risk factors among young men presenting to the Brazilian Army: a STROBE-compliant national survey-based cross-sectional observational study. Medicine. 2019;98(32):e16401. doi:10.1097/MD.0000000000016401
   PubMed Web of Science ®Google Scholar
• Gheorghe L, Csiki IE, Iacob S, Gheorghe C. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania: a nationwide survey. Eur J Gastroenterol Hepatol. 2013;25(1):56–64. doi:10.1097/MEG.0b013e328358b0bb
   PubMed Web of Science ®Google Scholar
• Umare A, Seyoum B, Gobena T, Haile Mariyam T. Hepatitis B virus infections and associated factors among pregnant women attending antenatal care clinic at deder hospital, Eastern Ethiopia. PLoS One. 2016;11(11):e0166936. doi:10.1371/journal.pone.0166936
   PubMed Web of Science ®Google Scholar
• Desalegn Z, Wassie L, Beyene HB, Mihret A, Ebstie YA. Hepatitis B and human immunodeficiency virus co-infection among pregnant women in resource-limited high endemic setting, Addis Ababa, Ethiopia: implications for prevention and control measures. Eur J Med Res. 2016;21(1):16. doi:10.1186/s40001-016-0211-3
   PubMedGoogle Scholar
• Yizengaw E, Getahun T, Geta M, et al. Sero-prevalence of hepatitis B virus infection and associated factors among health care workers and medical waste handlers in primary hospitals of North-west Ethiopia. BMC Res Notes. 2018;11(1):437. doi:10.1186/s13104-018-3538-8
   PubMedGoogle Scholar
• Moradi G, Gouya -M-M, Zavareh FA, et al. Prevalence and risk factors for HBV and HCV in prisoners in Iran: a national bio‐behavioural surveillance survey in 2015. Tropical Med Inter Health. 2018;23(6):641–649. doi:10.1111/tmi.13065
   PubMed Web of Science ®Google Scholar
• Agaba PA, Makai R, Bankat CT, et al. Sexual behavior and risk factors for HIV infection among young people aged 15-24 years in North-Central Nigeria. J Med Trop. 2016;18:60–67. doi:10.4103/2276-7096.192212
   Google Scholar
• Courtney LP, Goco N, Woja J, et al. HIV prevalence and behavioral risk factors in the Sudan People’s Liberation Army: data from South Sudan. PLoS One. 2017;12(11):e0187689. doi:10.1371/journal.pone.0187689
   PubMed Web of Science ®Google Scholar
• Giorgio M, Townsend L, Zembe Y, et al. HIV prevalence and risk factors among male foreign migrants in Cape Town, South Africa. AIDS Behav. 2017;21(3):949–961. doi:10.1007/s10461-016-1521-8
   PubMed Web of Science ®Google Scholar
• Djibo DA, Sahr F, McCutchan JA, et al. Prevalence and risk factors for human immunodeficiency virus (HIV) and syphilis infections among military personnel in Sierra Leone. Curr HIV Res. 2017;15(2):128–136. doi:10.2174/1570162X15666170517101349
   PubMed Web of Science ®Google Scholar
• Geberehiwet K. Prevalence of Hepatitis B virus, human immune deficiency virus and associated risk factors among individuals with presumptive pulmonary tuberculosis attending at St. Peter`s specialized hospital, addis Ababa, Ethiopia. Addis Ababa: University of Addis Ababa; 2020. Available from: http://etd.aau.edu.et/handle/123456789/23986. Accessed June 14, 2023.
   Google Scholar